Evidence map›Paper›PMID 37614706›Full record

ArticleFrontiers in chemistry2023

Rasha Fadhel Obaid, Fahad Alsaikhan, Hussam H Tizkam, Hassan Thoulfikar A Alamir, Hamad Jandari Jumaa, Ibrahem Waleed, Irfan Ahmad, Mohammed Shnain Ali, Mohmmed Asiri

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Retraction · 2024-05-23Concerns/Issues about Data · Investigation by Journal/Publisher · Objections by Author(s) · Unreliable Results and/or Conclusions ·
  • Retracted
5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Rasha Fadhel ObaidDepartment of Biomedical Engineering, Al-Mustaqbal University College, Babylon, Iraq.
Fahad AlsaikhanCollege of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Hussam H TizkamDepartment of Pharmacy, Al Safwa University College, Karbala, Iraq.
Hassan Thoulfikar A AlamirDepartment of Pharmaceutics, Faculty of Pharmacy, University of Al-Ameed, Karbala, Iraq.
Hamad Jandari JumaaDepartment of Nursing, Al-Hadba University College, Mosul, Iraq.
Ibrahem WaleedMedical Technical College, Al-Farahidi University, Baghdad, Iraq.
Irfan AhmadDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
Mohammed Shnain AliDepartment of Dentistry, Al-Zahrawi University College, Karbala, Iraq.
Mohmmed AsiriDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
University of Karbala · IQKing Khalid University · SAAl-Farahidi UniversityPrince Sattam Bin Abdulaziz University · SAUniversity of Babylon · IQUniversity of Mosul · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The investigation involved examining the binding of two lanthanide complexes, specifically those containing Holmium (Ho) and Dysprosium (Dy), with a ligand called 1, 10-phenanthroline (phen), and bovine serum albumin (BSA). The evaluation was carried out utilizing fluorescence measurements, Förster theory, and docking studies. The findings indicated that both the Ho-complex and Dy-complex possessed a significant ability to quench the emission of the protein. Furthermore, the primary mechanism of interaction was identified as a static process. The

Indexed as

anticancer activityantimicrobial activityBSA bindinglanthanide complexmolecular docking

Identifiers

PMID37614706
PMCPMC10442832
OpenAlexW4385660008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.